{"title":"The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review.","authors":"Roberta Elisa Rossi, Valeria Poletti, Benedetta Masoni, Angelo Zullo, Matteo Colombo, Cesare Hassan, Alessandro Repici","doi":"10.1080/17474124.2024.2422372","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Videocapsule endoscopy (VCE) may be a complementary tool in the diagnosis of celiac disease (CD) in cases with equivocal findings and in the follow-up of complicated cases. We aimed to summarize the literature on the utilization of VCE in CD diagnosis/follow-up.</p><p><strong>Methods: </strong>A computerized literature search was performed to identify pertinent articles published between January 2010 and January 2024.</p><p><strong>Results: </strong>Three studies focused on VCE in diagnosing CD, involving a total of 186 patients. VCE was performed due to small bowel atrophy with negative serology (19 patients), positive serology with negative histology (40 patients), contraindications/refusal to undergo esophagogastroduodenoscopy (6 patients), high clinical suspicion of CD despite negative serology and/or small bowel atrophy (99 patients), research purpose (22 patients). Twenty studies focused on the follow-up, involving a total of 1337 patients. VCE was performed due to positive serology despite GFD (64 patients), persistent symptoms (389 patients), known/suspected refractory CD-RCD (448 patients), not specified (436 patients). VCE revealed RCD in 243 patients, ulcerative jejunoileitis in 32, T-cell lymphoma in 18, small bowel tumor in one.</p><p><strong>Conclusions: </strong>VCE may play a role in patients with equivocal CD diagnosis and in those with suspected complications, particularly RCD. Further studies are warranted to draw more solid conclusions.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"673-679"},"PeriodicalIF":3.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474124.2024.2422372","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Videocapsule endoscopy (VCE) may be a complementary tool in the diagnosis of celiac disease (CD) in cases with equivocal findings and in the follow-up of complicated cases. We aimed to summarize the literature on the utilization of VCE in CD diagnosis/follow-up.
Methods: A computerized literature search was performed to identify pertinent articles published between January 2010 and January 2024.
Results: Three studies focused on VCE in diagnosing CD, involving a total of 186 patients. VCE was performed due to small bowel atrophy with negative serology (19 patients), positive serology with negative histology (40 patients), contraindications/refusal to undergo esophagogastroduodenoscopy (6 patients), high clinical suspicion of CD despite negative serology and/or small bowel atrophy (99 patients), research purpose (22 patients). Twenty studies focused on the follow-up, involving a total of 1337 patients. VCE was performed due to positive serology despite GFD (64 patients), persistent symptoms (389 patients), known/suspected refractory CD-RCD (448 patients), not specified (436 patients). VCE revealed RCD in 243 patients, ulcerative jejunoileitis in 32, T-cell lymphoma in 18, small bowel tumor in one.
Conclusions: VCE may play a role in patients with equivocal CD diagnosis and in those with suspected complications, particularly RCD. Further studies are warranted to draw more solid conclusions.
期刊介绍:
The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.